TAK1-binding protein 1 (TAB1)

TAK1-binding protein 1 (TAB1) is a regulatory subunit of TAK1 (transforming growth factor-beta-activated kinase 1), a mitogen-activated protein kinase kinase kinase (MAP3K7). TAB1 binds constitutively to TAK1 through its C-terminal region, promoting TAK1 oligomerization, autophosphorylation, and activation—especially in response to osmotic stress, though it is dispensable for cytokine-induced TAK1 activation. Structurally, TAB1 shares similarity with the PPM family of protein phosphatases but lacks key residues needed for enzymatic activity, classifying it as a pseudophosphatase. Functionally, TAB1 modulates key inflammatory and apoptotic signaling pathways in cooperation with TAK1 and other binding partners (TAB2, TAB3), thereby influencing innate immunity, inflammation, cellular responses to stress, and aspects of cell fate determination including apoptosis and necroptosis. TAB1 is not itself a classical therapeutic target; instead, it is an essential adaptor in the activation of TAK1 and its downstream signaling cascades.

Other names

TAB1RINGOMAP3K7 binding protein 1 (MAP3K7BP1)

TAB1 itself is not typically the direct molecular target of drugs. When targeted indirectly through the TAK1-TAB complex, mechanisms include inhibition of kinase activity and modulation of inflammatory signaling